Understanding biomarkers: what molecular tests can tell me about my tumour

Your report contains letters, numbers and perhaps the word “positive”. The same abbreviation appears in a trial description. Does that mean the trial is a match?

A biomarker can be an important clue. To understand it, separate three questions: what was measured, what does the result mean, and what decision can follow from it?

The diagnosis tells part of the story

A diagnosis identifies the type of cancer. Biomarkers add measurable characteristics, such as particular proteins or changes in the genetic material of cancer cells. Two tumours with the same diagnosis can differ in these features.

This can matter for treatment. A medicine designed to act on a particular feature of cancer cells needs that target to be present. Molecular testing helps establish whether it is there. Other markers give clues about the likely course of the disease. The word “biomarker” alone therefore does not tell you what a test is useful for.

A “positive” result is not yet a treatment decision

“Positive” may mean that the feature being tested was detected. Whether that opens a treatment option depends on the marker and the particular cancer. A laboratory report may also include changes whose significance is still unclear.

“What does this finding change about my treatment plan?” is therefore more useful than a general “Is that good or bad?” Ask your doctor to show you which part of the report informs the decision, and which entries currently have no practical consequence.

Why a trial still has other criteria

Imagine two people with the same cancer type and the same marker. One has already received several treatments; the other is about to start treatment. A trial may specifically address only one of these situations.

A matching marker answers one eligibility question. Others concern previous treatments and health status. This explains why an apparently matching report is not an offer of a trial place. When contacting the site, both the precise laboratory report and your treatment history matter.

What to take away from your report

Ask for a copy and an explanation of the relevant section. Note which marker was tested, the result and the next step it leads to. That might mean further assessment, consideration of a trial or no change to the existing plan.

If the report mentions a genetic change, also ask whether it was found only in the tumour or raises a possibility of an inherited change. A tumour test does not automatically answer that second question. Separate testing and counselling may be needed.

This information is not a substitute for a conversation with your doctor.